Form D · Other
DMD Therapeutics Inc.
Seattle, WA · CIK 0001681820
Offering snapshot reported Aug 11, 2016 · SEC filing
- Reported sold
- $0 Offering amount: $600K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Jul 26, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 11, 2016 | Initial | $0 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-268698
Investment contract
Source: Form D, filed Aug 11, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ronald Berenson | Director, Executive, Promoter |
Issuer details
Industry: Other (See others in industry)
Address:
2032 41st Avenue E
Seattle, WA, 98112
Seattle, WA, 98112